Page last updated: 2024-10-24

chloroquine and Armstrong Syndrome

chloroquine has been researched along with Armstrong Syndrome in 1 studies

Chloroquine: The prototypical antimalarial agent with a mechanism that is not well understood. It has also been used to treat rheumatoid arthritis, systemic lupus erythematosus, and in the systemic therapy of amebic liver abscesses.
chloroquine : An aminoquinoline that is quinoline which is substituted at position 4 by a [5-(diethylamino)pentan-2-yl]amino group at at position 7 by chlorine. It is used for the treatment of malaria, hepatic amoebiasis, lupus erythematosus, light-sensitive skin eruptions, and rheumatoid arthritis.

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Wang, C1
McPherson, AJ1
Jones, RB1
Kawamura, KS1
Lin, GH1
Lang, PA1
Ambagala, T1
Pellegrini, M1
Calzascia, T1
Aidarus, N1
Elford, AR1
Yue, FY1
Kremmer, E1
Kovacs, CM1
Benko, E1
Tremblay, C1
Routy, JP1
Bernard, NF1
Ostrowski, MA1
Ohashi, PS1
Watts, TH1

Other Studies

1 other study available for chloroquine and Armstrong Syndrome

ArticleYear
Loss of the signaling adaptor TRAF1 causes CD8+ T cell dysregulation during human and murine chronic infection.
    The Journal of experimental medicine, 2012, Jan-16, Volume: 209, Issue:1

    Topics: 4-1BB Ligand; Adoptive Transfer; Animals; Antibodies; CD8-Positive T-Lymphocytes; Chloroquine; Chron

2012